Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 237
Filter
1.
Anesth Analg ; 127(6): 1344-1350, 2018 12.
Article in English | MEDLINE | ID: mdl-30169407

ABSTRACT

BACKGROUND: Certain surgical interventions may require a deep neuromuscular block (NMB). Reversal of such a block before tracheal extubation is challenging. Because anticholinesterases are ineffective in deep block, sugammadex 4 mg/kg has been recommended for the reversal of rocuronium- or vecuronium-induced deep NMB. However, this recommendation requires opening 2 vials of 200 mg sugammadex, which results in an increase in drug costs. Therefore, we sought a less expensive solution for the induction and reversal of deep NMB. Although the optimal dose of sugammadex for antagonism of deep block from pipecuronium has not been established, data pertaining to moderate block are available. Accordingly, we hypothesized that sugammadex 2 mg/kg would be a proper dose to reverse deep pipecuronium block, enabling us to avoid cost increases. In the present study, we compared sugammadex 2 mg/kg with the standard dose of 4 mg/kg for reversal of deep block from pipecuronium. METHODS: This single-center, randomized, double-blind, 2 parallel-arms, noninferiority study comprised 50 patients undergoing general anesthesia with propofol, sevoflurane, fentanyl, and pipecuronium. Neuromuscular monitoring was performed with acceleromyography (TOF-Watch SX). Noninferiority margin was specified beforehand as an increase in reversal time of no >10% (corresponding to 1 minute for the primary outcome). When the block spontaneously recovered to posttetanic count 1, the patients randomly received sugammadex 2 or 4 mg/kg, and the time from the injection to the train-of-four (TOF) ratio of 1.0 was measured. Primary outcome was the time to achieve the normalized TOF ratio of 0.9 in a particular patient. Residual or recurrent postoperative NMB was additional end point. RESULTS: Each patient recovered to the normalized TOF ratio of 0.9. In the 2 mg/kg group, reversal time was 1.73 ± 1.03 minutes (95% confidence interval [CI], 1.33-2.13; n = 25), and in the 4 mg/kg group, reversal time was 1.42 ± 0.63 minutes (mean ± standard deviation) (95% CI, 1.17-1.67; n = 25). The mean difference in reversal times between the 2 groups was 0.31 minutes (95% CI, -0.18 to 0.8), and the upper limit of CI was below the noninferiority margin of 1 minute. Postoperative block did not occur. CONCLUSIONS: The effect of sugammadex 2 mg/kg was noninferior to that of 4 mg/kg in reversing posttetanic count-1 degree pipecuronium block. Sugammadex reversal of deep pipecuronium block appears to be effective.


Subject(s)
Neuromuscular Blockade/methods , Pipecuronium/therapeutic use , Sugammadex/administration & dosage , Sugammadex/pharmacokinetics , Adolescent , Adult , Aged , Airway Extubation , Anesthesia Recovery Period , Anesthesia, General/methods , Double-Blind Method , Drug Administration Schedule , Female , Fentanyl/administration & dosage , Humans , Male , Middle Aged , Neuromuscular Junction/drug effects , Neuromuscular Monitoring , Neuromuscular Nondepolarizing Agents , Pipecuronium/administration & dosage , Propofol/administration & dosage , Sevoflurane/administration & dosage , Young Adult
2.
Int J Pharm ; 531(2): 512-520, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28366806

ABSTRACT

Applying patient friendly and cost-efficient medications in healthcare will be a real challenge in the 21st century. Sugammadex is a selective, yet expensive agent used for the post-surgical reversal of neuromuscular block since 2008. A wide library of cyclodextrin-based follow-ups, having potentially similar affinity towards target aminosteroid type neuromuscular blocking agents has been established. Almost 20 compounds were assessed with respect to in vitro affinity against three commonly applied drugs. Based on the capillary electrophoretic screening, carboxymethylated and sulfobutylated gamma-cyclodextrin derivatives have the potential to be promising lead molecules for their affinity towards pipecuronium was identical or even superior to Sugammadex. Carboxymethylated gamma-cyclodextrin showed efficient and complete reversal of the pipecuronium induced neuromuscular block in an ex vivo rat diaphragm experiment.


Subject(s)
Neuromuscular Blockade , Neuromuscular Nondepolarizing Agents/pharmacology , Pipecuronium/pharmacology , Receptors, Artificial/chemistry , gamma-Cyclodextrins/pharmacology , Animals , Drug Design , Male , Rats , Rats, Wistar
3.
Klin Khir ; (1): 67-9, 2017.
Article in Ukrainian | MEDLINE | ID: mdl-30272925

ABSTRACT

Impact of a durable action of myorelaxant pipecuronium bromide on intraabdominal pressure (IAP) in rats in experimentally simulated acute peritonitis was studied. In the rats in purulent pancreatitis, іnduced by L-аrginin, IAP was in 4,5 times high (p < 0.001), than in intact laboratory animals. Pipecuronium bromide have lowered IAP by 33.4%, witnessing efficacy of application of myorelaxants in treatment of intraabdominal hypertension in purulent pancreatitis.


Subject(s)
Intra-Abdominal Hypertension/drug therapy , Neuromuscular Nondepolarizing Agents/pharmacology , Peritonitis/physiopathology , Pipecuronium/pharmacology , Acute Disease , Animals , Animals, Outbred Strains , Arginine/administration & dosage , Injections, Intramuscular , Injections, Intraperitoneal , Intra-Abdominal Hypertension/chemically induced , Intra-Abdominal Hypertension/complications , Intra-Abdominal Hypertension/physiopathology , Peritonitis/chemically induced , Peritonitis/complications , Rats
4.
Anesth Analg ; 121(2): 373-80, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25923435

ABSTRACT

BACKGROUND: Pipecuronium is a steroidal neuromuscular blocking agent. Sugammadex, a relaxant binding γ-cyclodextrin derivative, reverses the effect of rocuronium, vecuronium, and pancuronium. We investigated whether sugammadex reverses moderate pipecuronium-induced neuromuscular blockade (NMB) and the doses required to achieve reversal. METHODS: This single-center, randomized, double-blind, 5-group parallel-arm study comprised 50 patients undergoing general anesthesia with propofol, sevoflurane, fentanyl, and pipecuronium. Neuromuscular monitoring was performed with acceleromyography (TOF-Watch SX) according to international standards. When the NMB recovered spontaneously to train-of-four count 2, patients randomly received 1.0, 2.0, 3.0, or 4.0 mg/kg of sugammadex or placebo. Recovery time from sugammadex injection to normalized train-of-four (TOF) ratio 0.9 was the primary outcome variable. The recovery time from the sugammadex injection to final T1 was the secondary end point. Postoperative neuromuscular functions were also assessed. RESULTS: Each patient who received sugammadex recovered to a normalized TOF ratio of 0.9 within 5.0 minutes (95% lower confidence interval for the lowest dose 70.1%; for all doses 90.8%) and 79% of these patients reached a normalized TOF ratio 0.9 within 2.0 minutes (95% lower confidence interval for the lowest dose 26.7%; for all doses 63.7%). T1 recovered several minutes after the TOF ratio. No residual postoperative NMB was observed. CONCLUSIONS: Sugammadex adequately and rapidly reverses pipecuronium-induced moderate NMB during sevoflurane anesthesia. Once the train-of-four count has spontaneously returned to 2 responses following pipecuronium administration, a dose of 2.0 mg/kg of sugammadex is sufficient to reverse the NMB.


Subject(s)
Anesthesia, General/methods , Anesthetics, Inhalation , Antidotes/therapeutic use , Methyl Ethers , Neuromuscular Blockade/methods , Neuromuscular Blocking Agents/therapeutic use , Neuromuscular Junction Diseases/prevention & control , Neuromuscular Junction/drug effects , Pipecuronium/therapeutic use , gamma-Cyclodextrins/therapeutic use , Adult , Aged , Anesthesia Recovery Period , Double-Blind Method , Female , Humans , Hungary , Male , Middle Aged , Neuromuscular Blockade/adverse effects , Neuromuscular Blocking Agents/adverse effects , Neuromuscular Junction/physiopathology , Neuromuscular Junction Diseases/chemically induced , Neuromuscular Junction Diseases/diagnosis , Neuromuscular Junction Diseases/physiopathology , Neuromuscular Monitoring , Pipecuronium/adverse effects , Recovery of Function , Sevoflurane , Sugammadex , Time Factors , Treatment Outcome
5.
Anesteziol Reanimatol ; (4): 73-6, 2012.
Article in Russian | MEDLINE | ID: mdl-23082652

ABSTRACT

The paper analyzes the incidence of residual neuromuscular blockade (NMB) after pipecuronium and rocuronium administration in 124 neurosurgical patients. We analyzed neuromuscular conductance with TOF-Watch SX Residual NMB incidence after neuromuscular blocking agents administration in neurosurgical patients is 87.7%. Use of pipecuronium accompanied by a greater incidence and duration of residual NMB in comparison with rocuronium. Sugammadex administration is effective method of residual NMB reversal and can restore NMC in 3-5 minutes.


Subject(s)
Androstanols/pharmacology , Neuromuscular Blockade/methods , Pipecuronium/pharmacology , gamma-Cyclodextrins/pharmacology , Adult , Brain Injuries/physiopathology , Brain Injuries/surgery , Female , Humans , Male , Middle Aged , Neuromuscular Nondepolarizing Agents , Neurosurgical Procedures/methods , Rocuronium , Sugammadex , Time Factors , Trauma Severity Indices
6.
Eur J Anaesthesiol ; 26(5): 389-95, 2009 May.
Article in English | MEDLINE | ID: mdl-19521295

ABSTRACT

BACKGROUND AND OBJECTIVE: Porcine anaesthesia remains a great problem for cardiac surgery research and especially with cardiopulmonary bypass procedures. This study was designed to develop a suitable anaesthesia model in which miniature pigs could be induced smoothly and be maintained stably during and after a cardiopulmonary bypass procedure. METHODS: Thirty-one miniature pigs were randomly divided into two groups and induced using ketamine and pentobarbital (K-P group, n = 15) or pentobarbital (P group, n = 16) alone, respectively. Animals in group K-P were induced with intramuscular injections of ketamine 5 mg kg and pentobarbital 20 mg kg body weight, and those in group P were induced with pentobarbital 30 mg kg alone. After intubation and intravenous catheterization, group K-P was maintained by continuous infusion of ketamine and pentobarbital, and pentobarbital was withdrawn after cardiopulmonary bypass started. Group P received a continuous infusion of pentobarbital throughout the operation. In addition, both groups were injected hourly with midazolam and pipecuronium bolus to achieve optimal surgical conditions. RESULTS: All of the group K-P animals survived for 24 h postoperatively. Five of the group P animals died from anaesthesia-related respiratory and cardiac arrest: three after induction and two after extubation. The animals in group K-P had more stable haemodynamics and arterial blood gas indices than animals in group P. Furthermore, the percentage of animals achieving satisfactory anaesthetic effects was significantly higher in group K-P than in group P. CONCLUSION: Combination anaesthesia with low-dose ketamine and pentobarbital demonstrated superior haemodynamic and respiratory indices in comparison with pentobarbital. The combination regimen can achieve both hypnosis and analgesia effects with stable circulatory parameters.


Subject(s)
Anesthetics, Combined/administration & dosage , Cardiopulmonary Bypass/methods , Ketamine/administration & dosage , Pentobarbital/administration & dosage , Adjuvants, Anesthesia/administration & dosage , Anesthetics, Dissociative/administration & dosage , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Hemodynamics/drug effects , Injections, Intramuscular , Male , Midazolam/administration & dosage , Pipecuronium/administration & dosage , Random Allocation , Respiration/drug effects , Swine , Swine, Miniature
7.
Rev Bras Anestesiol ; 58(6): 582-92, 2008.
Article in English, Portuguese | MEDLINE | ID: mdl-19082405

ABSTRACT

BACKGROUND AND OBJECTIVES: Pipecuronium is a non-depolarizing neuromuscular blocker with similar properties to pancuronium, but without cardiovascular effects. Neuromuscular effects, conditions of tracheal intubation, and hemodynamic repercussions of two different doses of pipecuronium were evaluated. METHOD: Patients were divided into two groups according to the dose of pipecuronium: Group I (0.04 mg x kg(-1)) and Group II (0.05 mg x kg(-1)). Intramuscular midazolam (0.1 mg x kg(-1)) was administered 30 minutes before the surgery. Propofol (2.5 mg x kg(-1)), preceded by fentanyl (5 microg x kg(-1)) and pipecuronium (0.04 and 0.05 mg x kg(-1) for Groups I and II, respectively), was administered for anesthetic induction. Patients were ventilated with 100% oxygen via a face mask until a 75% reduction in the amplitude of the response to an isolated stimulus (1 Hz) is achieved, at which time laryngoscopy and intubation were carried out. Anesthetic maintenance was achieved with isoflurane (0.5 to 1%) with a mixture of 50% O2 and N2O. Mechanical ventilation was used to maintain P(ET)CO2 between 32 and 36 mmHg. The pharmacodynamics of pipecuronium was evaluated by acceleromyography. RESULTS: Mean times and standard deviation for the onset of action, clinical duration (T1(25%)), and recovery index (T1(25-75%)) were: Group I (122.10 +/- 4.18 sec, 49.63 +/- 9.54 min, and 48.21 +/- 6.72 min), and Group II (95.78 +/- 8.91 sec, 64.84 +/- 13.13 min, and 48.52 +/- 4.95 min). Onset of action, clinical duration, and conditions of tracheal intubation were significantly different for both groups. CONCLUSIONS: Pipecuronium at a dose of 0.05 mg x kg(-1) can be used in prolonged procedures in which cardiovascular changes should be avoided.


Subject(s)
Cardiovascular System/drug effects , Intubation, Intratracheal , Neuromuscular Nondepolarizing Agents/administration & dosage , Pipecuronium/administration & dosage , Adult , Humans , Middle Aged , Neuromuscular Nondepolarizing Agents/pharmacology , Pipecuronium/pharmacology
8.
Rev. bras. anestesiol ; 58(6): 582-592, nov.-dez. 2008. ilus, tab
Article in English, Portuguese | LILACS | ID: lil-497046

ABSTRACT

JUSTIFICATIVA E OBJETIVOS: O pipecurônio é um bloqueador neuromuscular não-despolarizante, com propriedades similares as do pancurônio, mas desprovido de efeitos cardiovasculares. Foram avaliados os efeitos neuromusculares, as condições de intubação traqueal e as repercussões hemodinâmicas de duas diferentes doses de pipecurônio. MÉTODO: Pacientes foram distribuídos em dois grupos de acordo com a dose de pipecurônio: Grupo I (0,04 mg.kg-1) e Grupo II (0,05 mg.kg-1). A medicação pré-anestésica consistiu em midazolam (0,1 mg.kg-1) por via muscular, 30 minutos antes da operação. A indução anestésica foi obtida com propofol (2,5 mg.kg-1) precedido de fentanil (5 µg.kg-1) e pipecurônio nas doses de 0,04 e 0,05 mg.kg-1 para os Grupos I e II, respectivamente. Os pacientes foram ventilados com O2 a 100 por cento sob máscara até a redução de 75 por cento da amplitude da resposta a estímulo isolado (1 Hz), quando foram realizadas a laringoscopia e intubação traqueal. O isoflurano (0,5 a 1 por cento) em mistura de O2 e N(2)0 a 50 por cento para a manutenção da anestesia, foi introduzido logo após a intubação traqueal. Os pacientes foram ventilados mecanicamente para manter P ET CO2 entre 32 e 36 mmHg. A farmacodinâmica do pipecurônio foi avaliada por aceleromiografia. RESULTADOS: Os tempos médios e desvios-padrão para o início de ação, duração clínica (T1(25 por cento)) e índice de recuperação (T1(25-75 por cento)) foram: Grupo I (122,10 ± 4,18 s, 49,63 ± 9,54 min e 48,21 ± 6,72 min) e Grupo II (95,78 ± 8,91 s, 64,84 ± 13,13 min e 48,52 ± 4,95 min). O início de ação, a duração clínica e as condições de intubação traqueal foram significativamente diferentes entre os grupos. CONCLUSÕES: O pipecurônio na dose 0,05 mg.kg-1 pode ser usado em procedimentos de longa duração, nos quais é desejável evitar alterações cardiocirculatórias.


BACKGROUND AND OBJECTIVES: Pipecuronium is a non-depolarizing neuromuscular blocker with similar properties to pancuronium, but without cardiovascular effects. Neuromuscular effects, conditions of tracheal intubation, and hemodynamic repercussions of two different doses of pipecuronium were evaluated. METHOD: Patients were divided into two groups according to the dose of pipecuronium: Group I (0.04 mg.kg-1) and Group II (0.05 mg.kg-1). Intramuscular midazolam (0.1 mg.kg-1) was administered 30 minutes before the surgery. Propofol (2.5 mg.kg-1), preceded by fentanyl (5 µg.kg-1) and pipecuronium (0.04 and 0.05 mg.kg-1 for Groups I and II, respectively), was administered for anesthetic induction. Patients were ventilated with 100 percent oxygen via a face mask until a 75 percent reduction in the amplitude of the response to an isolated stimulus (1 Hz) is achieved, at which time laryngoscopy and intubation were carried out. Anesthetic maintenance was achieved with isoflurane (0.5 to 1 percent) with a mixture of 50 percent O2 and N2O. Mechanical ventilation was used to maintain P ET CO2 between 32 and 36 mmHg. The pharmacodynamics of pipecuronium was evaluated by acceleromyography. RESULTS: Mean times and standard deviation for the onset of action, clinical duration (T1(25 percent)), and recovery index (T1(25-75 percent)) were: Group I (122.10 ± 4.18 sec, 49.63 ± 9.54 min, and 48.21 ± 6.72 min), and Group II (95.78 ± 8.91 sec, 64.84 ± 13.13 min, and 48.52 ± 4.95 min). Onset of action, clinical duration, and conditions of tracheal intubation were significantly different for both groups. CONCLUSIONS: Pipecuronium at a dose of 0.05 mg.kg-1 can be used in prolonged procedures in which cardiovascular changes should be avoided.


JUSTIFICATIVA Y OBJETIVOS: El pipecuronio es un bloqueador neuromuscular no despolarizador, con propiedades similares a las del pancuronio, pero desprovisto de efectos cardiovasculares. Se evaluaron los efectos neuromusculares, condiciones de intubación traqueal y las repercusiones hemodinámicas de de los diferentes dosis de pipecuronio. MÉTODO: Los pacientes fueron distribuidos en de los grupos de acuerdo a la dosis de pipecuronio: Grupo I (0,04 mg.kg-1) y Grupo II (0,05 mg.kg-1). La medicación preanestésica consistió en midazolam (0,1 mg.kg-1) por vía muscular, 30 minutos antes de la operación. La inducción anestésica se obtuvo con propofol (2,5 mg.kg-1) precedido del fentanil (5 µg.kg-1) y del pipecuronio en las dosis de 0,04 y 0,05 mg.kg-1 para los Grupos I y II, respectivamente. Los pacientes se ventilaron con O2 a 100 por ciento bajo máscara hasta la reducción de un 75 por ciento de la amplitud de la respuesta al estímulo aislado (1 Hz), cuando fueron realizadas la laringoscopía y la intubación traqueal. El isoflurano (0,5 a 1 por ciento) en mezcla de O2 y N(2)0 a un 50 por ciento para el mantenimiento de la anestesia, fue introducido a continuación de la intubación traqueal. Los pacientes fueron ventilados mecánicamente para mantener el P ET CO2 entre 32 y 36 mmHg. La farmacodinámica del pipecuronio se evaluó por aceleromiografía. RESULTADOS: Los tiempos promedios y desviaciones estándar para el inicio de acción, duración clínica (T1(25 por ciento)) e índice de recuperación (T1(25-75 por ciento)) fueron los siguientes: Grupo I (122,10 ± 4,18 seg, 49,63 ± 9,54 min y 48,21 ± 6,72 min) y Grupo II (95,78 ± 8,91 seg, 64,84 ± 13,13 min y 48,52 ± 4,95 min). El inicio de acción, la duración clínica y las condiciones de intubación traqueal fueron significativamente diferentes entre los grupos. CONCLUSIONES: El pipecuronio, en la dosis 0,05 mg.kg-1 puede ser usado en procedimientos de larga duración donde se desee evitar alteraciones ca...


Subject(s)
Humans , Hemodynamics , Pipecuronium/administration & dosage , Pipecuronium/pharmacokinetics , Pipecuronium/pharmacology
9.
Anaesthesia ; 63(7): 719-25, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18582257

ABSTRACT

Severe tetanus is characterised by muscle spasms and autonomic dysfunction. We recently reported the results of a randomised placebo controlled trial of magnesium sulphate infusions for the treatment of severe tetanus which showed magnesium was associated with improved muscle spasm and cardiovascular control. We hypothesised that magnesium controlled autonomic dysfunction by reducing catecholamine release and thus urinary excretion. Urinary adrenaline and noradrenaline concentrations were measured during the first 24 h of therapy in 180 adults with severe tetanus randomised to treatment with magnesium (n = 92) or placebo (n = 88). Magnesium therapy was associated with lower urinary adrenaline excretion and higher urinary noradrenaline excretion. High urinary adrenaline concentrations were associated with documented autonomic dysfunction. Patients given magnesium had significantly less autonomic dysfunction, required less cardiovascular stabilising drugs, and had lower urinary concentrations of adrenaline. These findings suggest adrenaline is important in the pathophysiology of severe tetanus and magnesium controls autonomic dysfunction by reducing adrenaline release.


Subject(s)
Anticonvulsants/pharmacology , Epinephrine/urine , Magnesium Sulfate/pharmacology , Norepinephrine/urine , Tetanus/urine , Adolescent , Adult , Aged , Anticonvulsants/blood , Anticonvulsants/therapeutic use , Blood Pressure/drug effects , Diazepam/pharmacology , Double-Blind Method , Female , Heart Rate/drug effects , Humans , Magnesium Sulfate/blood , Magnesium Sulfate/therapeutic use , Male , Middle Aged , Pipecuronium/pharmacology , Tetanus/blood , Tetanus/drug therapy
10.
J Chromatogr A ; 1201(2): 191-5, 2008 Aug 08.
Article in English | MEDLINE | ID: mdl-18533165

ABSTRACT

A sensitive and selective HPLC method with coulometric electrode array detection for the determination of pipecuronium bromide and its four impurities has been developed. The coulometric electrode array detection at increasing potentials from +300 to +900mV of the porous graphite electrode versus the palladium reference electrode was used. The limit of detection and quantitation for pipecuronium bromide was 8 and 25ngml(-1), respectively. This elaborate method for the simultaneous analysis of pipecuronium bromide and its impurities proved to be fast, precise, accurate, sensitive, and could be applied to analysis in substances and in pharmaceutical preparations.


Subject(s)
Chromatography, High Pressure Liquid/methods , Pharmaceutical Preparations/chemistry , Pipecuronium/analysis , Electrochemistry/methods , Electrodes , Pipecuronium/chemistry , Sensitivity and Specificity
12.
Acta Anaesthesiol Scand ; 51(4): 426-33, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17378780

ABSTRACT

BACKGROUND: Off-pump coronary artery bypass grafting (OPCAB) can be associated with severe cardiovascular changes, thus requiring advanced haemodynamic monitoring. Our aim was to investigate the feasibility of transpulmonary single thermodilution (STD) combined with pulse-contour analysis, a newly introduced method for cardiovascular monitoring, for assessment of changes in haemodynamics during different anaesthetic techniques in OPCAB. METHODS: Thirty-six patients scheduled for elective OPCAB were randomized to receive anaesthesia either with midazolam, propofol or isoflurane, in addition to fentanyl and pipecuronium. After catheterization of the femoral artery, haemodynamic parameters were assessed using STD and pulse-contour analysis. The measurements were performed after induction of anaesthesia, during surgery and at 2, 4 and 6 h post-operatively. RESULTS: At the end of surgery, the global ejection fraction decreased by 29% and 19% in the midazolam and the propofol groups, respectively, (P < 0.05) but remained unchanged in the isoflurane group. Moreover, in the isoflurane group, the left ventricular contractility index was higher and the mean arterial pressure (MAP) and the systemic vascular resistance index (SVRI) decreased in comparison with pre-operative values. Post-operatively, the cardiac index (CI) and the cardiac function index (CFI) increased in all groups (P < 0.05). The peri-operative requirement for ephedrine and nitroglycerin increased in the propofol and the midazolam groups, respectively (P < 0.05). CONCLUSION: During OPCAB, STD and pulse-contour analysis displayed changes in preload, myocardial function and afterload that gave valuable guidance for the conduct of anaesthesia, fluid management, and the administration of vasoactive agents. As assessed using STD, isoflurane within the present dose range appears to maintain myocardial performance and vascular tone better than midazolam or propofol.


Subject(s)
Anesthesia/methods , Blood Pressure/drug effects , Coronary Artery Bypass, Off-Pump/methods , Heart Rate/drug effects , Monitoring, Physiologic/methods , Vascular Resistance/drug effects , Aged , Anesthetics, Inhalation/administration & dosage , Anesthetics, Intravenous/administration & dosage , Coronary Artery Disease/surgery , Elective Surgical Procedures/methods , Feasibility Studies , Female , Fentanyl/administration & dosage , Heart Function Tests/methods , Humans , Isoflurane/administration & dosage , Male , Midazolam/administration & dosage , Middle Aged , Neuromuscular Nondepolarizing Agents/administration & dosage , Pipecuronium/administration & dosage , Propofol/administration & dosage , Stroke Volume/drug effects , Thermodilution/methods
13.
Anesth Analg ; 103(1): 103-9, table of contents, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16790635

ABSTRACT

Neuromuscular blocking drugs can induce intraoperative bronchospasm. We characterized the magnitude and the temporal profile of the constriction in normal or in hyperresponsive airways after injections of neuromuscular blocking drugs. Respiratory system impedance (Zrs) was measured continuously over a 90-s apneic period in naïve and rabbits sensitized to allergens by ovalbumin. Fifteen s after the start of Zrs recordings, succinylcholine, mivacurium, or pipecuronium was administered in random order. Zrs was then also recorded during the administration of increasing doses of exogenous histamine. To monitor the changes in the airway mechanics during these maneuvers, Zrs was averaged for 2-s time windows, and the airway resistance (Raw) was determined by model fitting. The increases in Raw were significantly larger in the sensitized rabbits than in the naïve animals. The largest increases in Raw and the maximum rate of change in Raw were obtained for succinylcholine (146% +/- 29% and 0.80 +/- 0.12 cm H2O/L, respectively) and mivacurium (80% +/- 25% and 0.71 +/- 0.13 cm H2O/L) and the smallest were obtained for pipecuronium (40% +/- 12% and 0.41 +/- 0.04 cm H2O/L). Allergic sensitization leads to severe and rapidly developing bronchospasm after administrations of mivacurium or succinylcholine. These deleterious side effects should be considered when succinylcholine or mivacurium is administered in the presence of bronchial hyperreactivity.


Subject(s)
Bronchial Hyperreactivity/physiopathology , Bronchoconstriction/drug effects , Neuromuscular Blocking Agents/pharmacology , Airway Resistance , Animals , Histamine/pharmacology , Isoquinolines/pharmacology , Mivacurium , Pipecuronium/pharmacology , Rabbits , Respiratory Hypersensitivity/physiopathology , Succinylcholine/pharmacology
14.
Rev. bras. anestesiol ; 55(4): 381-386, jul.-ago. 2005. tab
Article in Portuguese, English | LILACS | ID: lil-416899

ABSTRACT

JUSTIFICATIVA E OBJETIVOS: Uma das mais importantes propriedades dos bloqueadores neuromusculares é o rápido início de ação, possibilitando intubação traqueal precoce. A administração de pequena dose de bloqueador não-despolarizante antes da dose plena é sabidamente redutora da latência da maioria dos bloqueadores neuromusculares utilizados. O brometo de pipecurônio é um agente aminoesteróide de longa duração com grande estabilidade cardiovascular, porém, com início de ação tardio. O objetivo desse estudo foi avaliar o efeito do priming do pipecurônio em pacientes adultos submetidos a cirurgias eletivas sob anestesia geral. MÉTODO: Foram estudados 33 pacientes adultos de ambos os sexos, com idade entre 20 e 65 anos, estado físico ASA I ou II, submetidos a cirurgias eletivas sob anestesia geral. Foram excluídos do estudo pacientes com insuficiência renal ou hepática, neuromiopatia, uso concomitante de drogas que influenciem a sua farmacocinética ou pacientes com histórico familiar de hipertermia maligna. Foram divididos em dois grupos: Grupo 1 onde foi utilizado o priming com 0,01 mg.kg-1 e três minutos depois completada a dose de 0,08 mg.kg-1 e o Grupo 2, sem dose priming (Grupo Controle). O relaxamento neuromuscular foi controlado pela aceleromiografia (Aparelho TOF-Guard) e no momento em que T1 < 10 por cento era realizada a laringoscopia. A análise estatística foi feita pelos testes T para amostras independentes e a normalidade pelo Shapiro Wilks. RESULTADOS: Os grupos foram homogêneos e observou-se que o tempo para T1 < 10 por cento no Grupo 1 foi de 161,4 ± 13,7 segundos e no Grupo 2 foi 217,8 ± 23,4 segundos, com p < 0,001, havendo diferença estatística significativa entre os grupos. CONCLUSÕES: Os resultados do estudo mostraram diferença estatística significativa entre os grupos com e sem priming, indicando que o pipecurônio também tem latência reduzida, assim como os demais bloqueadores neuromusculares conhecidos.


Subject(s)
Male , Female , Adult , Middle Aged , Humans , Neuromuscular Nondepolarizing Agents/administration & dosage , Muscle Contraction , Neuromuscular Blockade , Pipecuronium/administration & dosage
15.
Anesteziol Reanimatol ; (5): 49-52, 2004.
Article in Russian | MEDLINE | ID: mdl-15573726

ABSTRACT

The experience of clinical use of the new Russian myorelaxant of the non-depolarizing action vero-pipecuronium (pipecuronium bromided) manufactured by "Veropharm" is described. Vero-pipecuronium was found to ensure splendid and good conditions for the intubation of the trachea and to maintain reliably myorelaxation. The recommended doses and availability of an antidote (prozerine) provide for a sufficiently controllable myorelaxation. Vero-pipecuronium does not virtually exert any effect on the parameters of hemodynamics and can be successfully used in patients with a high anesthetic risk including heart surgeries. Thus, Russian vero-pipecuronium has now an effective and safe myorelaxant manufactured inside the country, whose parameters are not inferior to those of pipecuronium bromide (arduan) manufactured by "Gedeon Richter", Hungary. Since the described drug is made in Russia, one can hope it will be highly effective both economically and pharmacologically.


Subject(s)
Abdomen/surgery , Anesthesia, General , Muscle Relaxation/drug effects , Neuromuscular Nondepolarizing Agents/therapeutic use , Pipecuronium/therapeutic use , Thoracic Surgery/methods , Adult , Aged , Aged, 80 and over , Hemodynamics/drug effects , Humans , Intubation, Intratracheal , Middle Aged , Monitoring, Intraoperative , Neuromuscular Nondepolarizing Agents/administration & dosage , Pipecuronium/administration & dosage
18.
Anal Bioanal Chem ; 377(5): 852-62, 2003 Nov.
Article in English | MEDLINE | ID: mdl-12937879

ABSTRACT

A system is proposed for the classification of related organic impurities in drugs and drug products including among others (separated and non-separated) intermediates, various kinds of by-products, among them products of different side reactions, epimeric/diastereomeric, enantiomeric impurities, impurities in natural products, and finally degradation products. Examples are taken mainly from the author's own experience and from among the named impurities in the European Pharmacopoeia with focus on impurities in hydrocortisone, prednisolone, enalapril maleate, lisinopril, ethynodiol diacetate, pipecuronium bromide, cimetidine, and ethynylsteroids. The methodological aspects of impurity profiling from the detection to the identification/structure elucidation and quantitative determination of impurities are briefly summarized.


Subject(s)
Drug Contamination , Organic Chemicals/analysis , Pharmaceutical Preparations/isolation & purification , Cimetidine/chemistry , Cimetidine/isolation & purification , Enalapril/chemistry , Enalapril/isolation & purification , Ethynodiol Diacetate/chemistry , Ethynodiol Diacetate/isolation & purification , Hydrocortisone/chemistry , Hydrocortisone/isolation & purification , Lisinopril/chemistry , Lisinopril/isolation & purification , Norethindrone/chemistry , Norethindrone/isolation & purification , Norgestrel/chemistry , Norgestrel/isolation & purification , Pharmaceutical Preparations/chemistry , Pipecuronium/chemistry , Pipecuronium/isolation & purification , Prednisolone/chemistry , Prednisolone/isolation & purification
19.
Acta Pharm Hung ; 72(1): 37-48, 2002.
Article in Hungarian | MEDLINE | ID: mdl-12426786

ABSTRACT

Investigation of new neuromuscular blocking agents was started 30 years ago in Richter Ltd. This paper presents the results obtained by Richter's scientists. 2 compounds out of 100 bisquaternary ammonio steroid having androstane skeleton were selected for further pharmacological study. One of these agents, pipecuronium bromide (Arduan) elicited long-lasting block of neuromuscular transmission without cardiovascular side effects in both animal experiments and clinical studies. Arduan is a powerful competitive antagonist of acetylcholine, since it can bind pre- and postsynaptic (N1) receptors of the transmitters. It has no remarkable cumulative effect. Neostigmine rapidly and completely antagonized the neuromuscular blockade caused by pipecuronium. Arduan was introduced into clinical practice. The second compound, RGH-4201 (Duador) evoked a neuromuscular block of short duration. It showed slight atropin-like cardio-vagolytic effect in animal experiments. In the clinical studies, however, the cardiovascular side effects were found to be too strong. Therefore, it was not introduced in clinical practice.


Subject(s)
Neuromuscular Blocking Agents/pharmacology , Neuromuscular Blocking Agents/therapeutic use , Androstanes/pharmacology , Androstanes/therapeutic use , Animals , Drug Industry , Humans , Hungary , Pipecuronium/pharmacology , Pipecuronium/therapeutic use , Quaternary Ammonium Compounds/pharmacology , Quaternary Ammonium Compounds/therapeutic use , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
20.
Anesteziol Reanimatol ; (5): 70-1, 2002.
Article in Russian | MEDLINE | ID: mdl-12611306

ABSTRACT

A total of 108 patients operated on the abdominal cavity were examined with laparoscopic equipment or via laparotomic assess. The recovery time of neuromuscular conduction was defined for a myorelaxant with organ-depended metabolism (pipecuronium) and, predominantly, nonorgan-depended metabolism (athracurium and cisathracurium) in relation to the type of surgical technique (laparoscopy and laparotomy). It is concluded that carboxyperitoneum prolongs the recovery of neuromuscular conduction for pipecuronium without affecting this parameter in athracurium and cisathracurium. It is more expedient to use these myorelaxants during laparoscopic operations than pipecuronium, a myorelaxant having organ-dependent metabolism.


Subject(s)
Anesthesia, Intravenous , Atracurium/analogs & derivatives , Laparoscopy , Muscle Relaxation/drug effects , Neuromuscular Blockade/methods , Neuromuscular Nondepolarizing Agents/metabolism , Adult , Aged , Atracurium/metabolism , Atracurium/pharmacology , Female , Humans , Intubation, Intratracheal/methods , Male , Middle Aged , Monitoring, Intraoperative , Neuromuscular Nondepolarizing Agents/pharmacology , Pipecuronium/metabolism , Pipecuronium/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...